MedPath
NMPA Approval

Methylphenidate Hydrochloride for Sustained-release Suspension

国药准字HJ20230150

December 29, 2023

Drug Information

盐酸哌甲酯缓释干混悬剂

口服混悬剂

300mg

化学药品

December 29, 2023

December 28, 2028

Company Information

Applicant Company

2033 Us Highway 130, Monmouth Junction, NJ 08852 United States of America

Manufacturing Company

TRIS PHARMA, INC.

2033 US 130, Monmouth Junction, NJ 08852 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.